3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy* / Q000401:mortality; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy / Q000401:mortality; D016027:Heart Transplantation / Q000706:statistics & numerical data; D006801:Humans; D008790:Metoprolol / Q000009:adverse effects / Q000627:therapeutic use*; D013548:Sweden / Q000453:epidemiology
D000319:Adrenergic beta-Antagonists; D008790:Metoprolol